Mesoblast (MEOBF) Current Assets (2017 - 2025)

Mesoblast (MEOBF) has disclosed Current Assets for 9 consecutive years, with $204.4 million as the latest value for Q2 2025.

  • Quarterly Current Assets rose 136.34% to $204.4 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $204.4 million through Jun 2025, up 136.34% year-over-year, with the annual reading at $204.4 million for FY2025, 136.34% up from the prior year.
  • Current Assets hit $204.4 million in Q2 2025 for Mesoblast, up from $86.5 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $204.4 million in Q2 2025 to a low of $69.8 million in Q2 2022.
  • Historically, Current Assets has averaged $118.1 million across 5 years, with a median of $86.5 million in 2024.
  • Biggest five-year swings in Current Assets: plummeted 52.89% in 2022 and later surged 136.34% in 2025.
  • Year by year, Current Assets stood at $148.2 million in 2021, then tumbled by 52.89% to $69.8 million in 2022, then increased by 16.93% to $81.7 million in 2023, then rose by 5.88% to $86.5 million in 2024, then soared by 136.34% to $204.4 million in 2025.
  • Business Quant data shows Current Assets for MEOBF at $204.4 million in Q2 2025, $86.5 million in Q2 2024, and $81.7 million in Q2 2023.